Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.
Fifty-seven patients with testicular tumors have been treated with combined chemotherapy (vinblastine, bleomycin and cisplatinum). By evaluation of therapeutic activity and toxic effects it was shown that Platidiam, Lachema, effectivity was identical with the two other cisplatinum preparations used in this study.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D013736:Testicular Neoplasms / Q000188:drug therapy*; D013810:Therapeutic Equivalency; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects
D001761:Bleomycin; D014747:Vinblastine; D002945:Cisplatin